Pharmaceuticals and the Internet Drug Regulatory Authorities' Perspective - Joint NLN-WHI Workshop, 24-25 September 2001
(2002; 80 pages)

Table of Contents

	Executive Summary
	Overview of activities by the World Health Organization - Dr Lembit Rägo
	Overview of activities by the Nordic Council on Medicines - Dr Ola Westbye
	Country Experiences
		Sweden: Publication bias of clinical trials - Dr Juliette Säwe
		The Netherlands: Pharmaceuticals and e-commerce - Dr Hans Heuvelmans
		Denmark: Web site of the Institute for Rational Pharmacotherapy - Ms Karin Friis Bach
		Denmark: Danish Medicines Agency web site - Mr Karsten Jørgensen
		South Africa: The South African perspective on medicine regulation - Dr Wilbert Bannenberg
		Tunisia - Dr Amor Toumi
		Estonia - Dr Main Uusküla
		Bulgaria: Bulgarian Drug Agency - Rozalina Asenova Kulaksazova
	The Danish Consumer Council - Ms Margrethe Nielsen
	Swedish Industry Association - Dr Håkan Mandahl
	Introduction to discussion points - Dr Lembit Rägo
	Quality aspects - Dr Ola Westbye
	Pilot study on drug regulatory web sites: Current status and future challenges - Ms Elodie Jambert
	The WHO model web site for drug regulatory authorities - Dr Lembit Rägo, Ms Elodie Jambert, Mr Jorg Hetzke
	Concluding discussion
	Annexes
		Annex 1. List of Participants
		Annex 2. List of DRA web sites
	References
	Back cover

Pharmaceuticals and the Internet Drug Regulatory Authorities' Perspective - Joint NLN-WHI Workshop, 24-25 September 2001

24-25 September 2001, Copenhagen, Denmark

NLN Publication Number 56

WHO Library Cataloguing-in-Publication Data

Pharmaceuticals and the internet: drug regulatory authorities’ perspective

(NLN publication; no. 56)

Jointly published by the Nordic Council on Medicines (NLN) and the World Health Organization; includes the report of the NLN Conference 2001 on Pharmaceuticals and the Internet, 24-25 September 2001, organized in collaboration with the World Health Organization.

1. Legislation, Drug 2. Internet - standards 3. Drug and narcotic control - methods I. NLN Conference on Pharmaceuticals and the Internet (2001: Copenhagen, Denmark) II. Series

ISBN 92 4 159006 8

(NLM classification: QV 33)

The World Health Organization welcomes requests for permission to reproduce or translate its publications, in part or in full. Applications and enquiries should be addressed to the Office of Publications, World Health Organization, Geneva, Switzerland, which will be glad to provide the latest information on any changes made to the text, plans for new editions, and reprints and translations already available.

The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the Secretariat of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries.

The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.

Printed and bound in Malta by Interprint Limited